U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Frontal balding

MedGen UID:
355251
Concept ID:
C1864584
Finding
Synonym: Frontal balding (male pattern baldness)
 
HPO: HP:0002292

Definition

Absence of hair in the anterior midline and/or parietal areas. [from HPO]

Term Hierarchy

Conditions with this feature

Chromosome 1q21.1 deletion syndrome
MedGen UID:
393913
Concept ID:
C2675897
Congenital Abnormality
The 1q21.1 recurrent microdeletion itself does not appear to lead to a clinically recognizable syndrome as some persons with the deletion have no obvious clinical findings and others have variable findings that most commonly include microcephaly (50%), mild intellectual disability (30%), mildly dysmorphic facial features, and eye abnormalities (26%). Other findings can include cardiac defects, genitourinary anomalies, skeletal malformations, and seizures (~15%). Psychiatric and behavioral abnormalities can include autism spectrum disorders, attention deficit hyperactivity disorder, autistic features, and sleep disturbances.
Myotonic dystrophy type 2
MedGen UID:
419137
Concept ID:
C2931689
Disease or Syndrome
Myotonic dystrophy type 2 (DM2) is characterized by myotonia and muscle dysfunction (proximal and axial weakness, myalgia, and stiffness), and less commonly by posterior subcapsular cataracts, cardiac conduction defects, insulin-insensitive type 2 diabetes mellitus, and other endocrine abnormalities. While myotonia (involuntary muscle contraction with delayed relaxation) has been reported during the first decade, onset is typically in the third to fourth decade, most commonly with fluctuating or episodic muscle pain that can be debilitating and proximal and axial weakness of the neck flexors and the hip flexors. Subsequently, weakness occurs in the elbow extensors and finger flexors. Facial weakness and weakness of the ankle dorsiflexors are less common. Myotonia rarely causes severe symptoms. In a subset of individuals, calf hypertrophy in combination with brisk reflexes is notable.
Steinert myotonic dystrophy syndrome
MedGen UID:
886881
Concept ID:
C3250443
Disease or Syndrome
Myotonic dystrophy type 1 (DM1) is a multisystem disorder that affects skeletal and smooth muscle as well as the eye, heart, endocrine system, and central nervous system. The clinical findings, which span a continuum from mild to severe, have been categorized into three somewhat overlapping phenotypes: mild, classic, and congenital. Mild DM1 is characterized by cataract and mild myotonia (sustained muscle contraction); life span is normal. Classic DM1 is characterized by muscle weakness and wasting, myotonia, cataract, and often cardiac conduction abnormalities; adults may become physically disabled and may have a shortened life span. Congenital DM1 is characterized by hypotonia and severe generalized weakness at birth, often with respiratory insufficiency and early death; intellectual disability is common.

Professional guidelines

PubMed

Nestor MS, Ablon G, Gade A, Han H, Fischer DL
J Cosmet Dermatol 2021 Dec;20(12):3759-3781. Epub 2021 Nov 6 doi: 10.1111/jocd.14537. PMID: 34741573Free PMC Article
Starace M, Orlando G, Alessandrini A, Piraccini BM
Am J Clin Dermatol 2020 Feb;21(1):69-84. doi: 10.1007/s40257-019-00479-x. PMID: 31677111
Wolff H, Fischer TW, Blume-Peytavi U
Dtsch Arztebl Int 2016 May 27;113(21):377-86. doi: 10.3238/arztebl.2016.0377. PMID: 27504707Free PMC Article

Recent clinical studies

Etiology

Thomas JA, Antonelli JA, Banez LL, Hoyo C, Grant D, Demark-Wahnefried W, Platz EA, Gerber L, Shuler K, Eyoh E, Calloway E, Freedland SJ
Cancer Causes Control 2013 May;24(5):1045-52. Epub 2013 Mar 26 doi: 10.1007/s10552-013-0182-4. PMID: 23529469Free PMC Article
Hayes VM, Severi G, Padilla EJ, Morris HA, Tilley WD, Southey MC, English DR, Sutherland RL, Hopper JL, Boyle P, Giles GG
Int J Cancer 2007 Feb 15;120(4):776-80. doi: 10.1002/ijc.22408. PMID: 17136762
New MI
J Clin Endocrinol Metab 2006 Nov;91(11):4205-14. Epub 2006 Aug 15 doi: 10.1210/jc.2006-1645. PMID: 16912124

Diagnosis

Alpañés M, González-Casbas JM, Sánchez J, Pián H, Escobar-Morreale HF
J Clin Endocrinol Metab 2012 Aug;97(8):2584-8. Epub 2012 Jun 5 doi: 10.1210/jc.2012-1683. PMID: 22669303
New MI
J Clin Endocrinol Metab 2006 Nov;91(11):4205-14. Epub 2006 Aug 15 doi: 10.1210/jc.2006-1645. PMID: 16912124
Hoffmann R
Dermatology 2005;211(1):54-62. doi: 10.1159/000085581. PMID: 15983438
Jozefowicz RF, Griggs RC
Neurol Clin 1988 Aug;6(3):455-72. PMID: 3065594
Belin MW, Baltch AL, Hay PB
Am J Ophthalmol 1981 Aug;92(2):210-4. doi: 10.1016/0002-9394(81)90773-x. PMID: 7023241

Therapy

Chantler DJ, Gordon D, Millan D, Panarelli M
BMJ Case Rep 2011 Apr 26;2011 doi: 10.1136/bcr.01.2011.3730. PMID: 22696667Free PMC Article
Belin MW, Baltch AL, Hay PB
Am J Ophthalmol 1981 Aug;92(2):210-4. doi: 10.1016/0002-9394(81)90773-x. PMID: 7023241

Prognosis

Hayes VM, Severi G, Padilla EJ, Morris HA, Tilley WD, Southey MC, English DR, Sutherland RL, Hopper JL, Boyle P, Giles GG
Int J Cancer 2007 Feb 15;120(4):776-80. doi: 10.1002/ijc.22408. PMID: 17136762

Clinical prediction guides

Thomas JA, Antonelli JA, Banez LL, Hoyo C, Grant D, Demark-Wahnefried W, Platz EA, Gerber L, Shuler K, Eyoh E, Calloway E, Freedland SJ
Cancer Causes Control 2013 May;24(5):1045-52. Epub 2013 Mar 26 doi: 10.1007/s10552-013-0182-4. PMID: 23529469Free PMC Article

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...